Predict your next investment

Venture Capital
vertical-group.com

See what CB Insights has to offer

Investments

135

Portfolio Exits

26

Funds

1

About The Vertical Group

The Vertical Group is a venture capital firm that is focused on the fields of medical technology and biotechnology. For more than 30 years, the principals of The Vertical Group have been founders, early stage investors, major shareholders, and executives of many of the medical technology industry's companies. The Vertical Group manages private partnerships with a "vertical" range of investments including: early and late venture stage companies; private operating companies involved in buy-out or corporate spin-off transactions; and public companies of all sizes. The Vertical Group is the successor to the venture capital division of F. Eberstadt & Co., and has been an independent firm since 1988.

The Vertical Group Headquarter Location

106 Allen Road Suite 207

Basking Ridge, New Jersey, 7920,

United States

908-277-3737

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing The Vertical Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find The Vertical Group in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Research containing The Vertical Group

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned The Vertical Group in 1 CB Insights research brief, most recently on Feb 2, 2021.

Latest The Vertical Group News

MicroTransponder Raises $53M in Series E

Jun 24, 2022

AUSTIN, TX, MicroTransponder closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG Ventures and Exceller Hunt Ventures return as existing investors alongside new venture investors that include Osage University Partners, Action Potential Venture Capital and The Vertical Group. Vivistim is MicroTransponder's first FDA-approved use of its novel neuroplasticity-based medical device platform. Vivistim is designed to enhance daily living for people suffering from neurological conditions that impair sensory and motor function. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

The Vertical Group Investments

135 Investments

The Vertical Group has made 135 investments. Their latest investment was in MicroTransponder as part of their Series E on June 6, 2022.

CBI Logo

The Vertical Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/20/2022

Series E

MicroTransponder

$53M

Yes

4

4/19/2022

Series B

Carlsmed

$30M

No

4

12/22/2021

Seed VC

El Camino Real Medical

$0.32M

Yes

1

12/22/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

7/13/2021

Series E

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/20/2022

4/19/2022

12/22/2021

12/22/2021

7/13/2021

Round

Series E

Series B

Seed VC

Seed VC

Series E

Company

MicroTransponder

Carlsmed

El Camino Real Medical

Subscribe to see more

Subscribe to see more

Amount

$53M

$30M

$0.32M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

4

1

10

10

The Vertical Group Portfolio Exits

26 Portfolio Exits

The Vertical Group has 26 portfolio exits. Their latest portfolio exit was Biorez on August 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/1/2022

Acquired

$99M

4

7/11/2022

Acquired

$99M

9

9/15/2020

IPO

$99M

Public

5

4/4/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

5/6/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/1/2022

7/11/2022

9/15/2020

4/4/2019

5/6/2016

Exit

Acquired

Acquired

IPO

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

4

9

5

10

10

The Vertical Group Acquisitions

2 Acquisitions

The Vertical Group acquired 2 companies. Their latest acquisition was Wright Medical Group on December 20, 1999.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/20/1999

Other Venture Capital

$99M

$26.61M

Acquired

3

12/19/1990

Growth Equity

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

12/20/1999

12/19/1990

Investment Stage

Other Venture Capital

Growth Equity

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$26.61M

$99M

Note

Acquired

Subscribe to see more

Sources

3

10

The Vertical Group Fund History

1 Fund History

The Vertical Group has 1 fund, including Vertical Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2005

Vertical Fund I

Multi-Stage Venture Capital

Closed

$381M

1

Closing Date

12/31/2005

Fund

Vertical Fund I

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

$381M

Sources

1

The Vertical Group Team

9 Team Members

The Vertical Group has 9 team members, including current Founder, Managing Director, General Partner, Richard Emmitt.

Name

Work History

Title

Status

Tony M. Chou

Founder

Current

Richard Emmitt

Founder, Managing Director, General Partner

Current

John A Slattery

Chief Financial Officer

Current

Dick Anderson

Executive Vice President

Current

Yue-Teh Jang

General Partner

Current

Name

Tony M. Chou

Richard Emmitt

John A Slattery

Dick Anderson

Yue-Teh Jang

Work History

Title

Founder

Founder, Managing Director, General Partner

Chief Financial Officer

Executive Vice President

General Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.